CMND-100 Completes Phase I/II Part A in Alcohol Use Disorder Trial
Clearmind Medicine has finished treating all Part A participants in its Phase I/II study of CMND-100, a novel nonhalluc…
Clearmind Medicine has finished treating all Part A participants in its Phase I/II study of CMND-100, a novel nonhalluc…
Pladis Global sets a 2030 commitment to double volume share of products with lower sugar, salt, and saturated fat along…
Pladis sets a 2030 reformulation target across its global biscuit and confectionery portfolio, prioritizing reduced sug…
pladis Global is targeting a 2030 portfolio shift across its biscuit and confectionery brands, prioritizing products wi…
Pladis is doubling down on nutritional reformulation across its global biscuit and confectionery portfolio, targeting l…
pladis, the global biscuit and confectionery group behind McVitie's, GODIVA, and Ülker, has set a 2030 reformulation ta…
Pladis sets a portfolio-wide reformulation target, prioritizing lower sugar, salt, and saturated fat alongside elevated…
Rapid Nutrition is using AI-powered commercial intelligence to accelerate its Premium Nutrition Pantry brand portfolio,…
Barfresh's Ohio expansion adds 50 school districts and more than 300,000 student consumers, signaling growing instituti…
GORGIE's Candy Apple launch extends a no-artificial-sweetener energy lineup now holding nearly 20% category share at a …
Volunteer Botanicals' Inner Wild line pairs mineral spring water with a proprietary bioavailability platform to target …
Veru's PLATEAU trial, pairing the SARM enobosarm with semaglutide, has surpassed its 200-patient enrollment target, a m…